Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.20.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Operating expenses:      
Research and development $ 27,363 $ 18,136 $ 6,469
General and administrative 9,979 6,590 2,280
Total operating expenses 37,342 24,726 8,749
Loss from operations (37,342) (24,726) (8,749)
Interest income 2,255 1,559 232
Net loss $ (35,087) $ (23,167) $ (8,517)
Net loss per common share, basic and diluted $ (1.84) $ (2.26) $ (14.21)
Weighted-average shares used to compute net loss per common share, basic and diluted 19,083,826 10,264,584 599,291